LSD:抑郁症治疗的机制和相关性
Amel Bouloufa1, Sarah Delcourte1, Thomas Delannay1
1Univ Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron 69500, France.
Neuroscience and biobehavioral reviews
|October 11, 2025
概括
Lysergic acid diethylamide (LSD) 在治疗主要抑郁症 (MDD) 和治疗耐药性抑郁症 (TRD) 中表现有前途. 这种迷幻药可以通过增强神经可塑性来提供快速,长期的缓解,为那些对传统抗抑郁药无反应的患者提供希望.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型抑郁症 (MDD) 影响全球超过3.5亿人,标准的单胺基抗抑郁药对许多人来说提供了不足的缓解.
- 治疗耐药性抑郁症 (TRD),影响30%的MDD患者,需要新的治疗策略.
研究的目的:
- 审查 lysergic acid diethylamide (LSD) 的神经生物学机制. 为了审查 lysergic acid diethylamide (LSD) 的神经生物学机制.
- 评估LSD作为抗抑郁药和抗焦虑剂的潜力.
- 讨论在精神病治疗中使用LSD的安全考虑.
主要方法:
- 对现有关于LSD影响的研究进行叙述性审查.
- 检查神经生物学途径,包括血清和葡萄糖的系统.
- 分析正在进行的临床试验的疗效,安全性,安慰剂设计和降低风险.
主要成果:
- LSD显示出快速和持续抗抑郁作用的潜力,可能是通过促进神经可塑性和改变神经通信.
- 临床试验正在积极调查LSD对TRD的疗效和安全性.
结论:
- 基于LSD的迷幻疗法代表了精神病治疗中的潜在范式转变.
- 这些疗法为治疗耐药抑郁症患者提供了新的希望.
- 进一步的研究对于验证发现和指导临床整合至关重要.
相关概念视频
Electroconvulsive Therapy
891
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
891
Long-term Depression
33.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.1K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Hallucinogens and Psychedelics
602
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
602
Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
Depression: Overview
781
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
781


